LEANZA, LUIGI

LEANZA, LUIGI  

Dipartimento di Biologia - DiBio  

Mostra records
Risultati 1 - 20 di 65 (tempo di esecuzione: 0.041 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
A Meta-Analysis Study to Infer Voltage-Gated K+ Channels Prognostic Value in Different Cancer Types 2023 Beatrice AngiSilvia MuccioliIldiko SzaboLuigi Leanza ANTIOXIDANTS - -
A novel mitochondrial kv1.3–caveolin axis controls cell survival and apoptosis 2021 Peruzzo R.Leanza L.Szabo I. + ELIFE - -
Activation of guanine-beta-d-arabinofuranoside and deoxyguanosine to triphosphates by a common pathway blocks T lymphoblasts at different checkpoints 2010 LEANZA, LUIGIMIAZZI, CRISTINAFERRARO, PAOLABIANCHI, VERA + EXPERIMENTAL CELL RESEARCH - -
BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway 2024 Prosdocimi E.Carpanese V.Todesca L. M.Varanita T.Festa M.Bonesso D.Velle A.Peruzzo R.Doni D.Leanza L.Costantini P.Cendron L.Romualdi C.Checchetto V.Szabo I. + SCIENCE ADVANCES - -
Biophysical Characterization and Expression Analysis of Kv1.3 Potassium Channel in Primary Human Leukemic B Cells 2015 SZABO', ILDIKO'TRENTIN, LIVIOTRIMARCO, VALENTINASEMENZATO, GIANPIETRO CARLOLEANZA, LUIGI CELLULAR PHYSIOLOGY AND BIOCHEMISTRY - -
Biophysical Characterization of the Potassium Channel Kv1.3 in B Cells from Patients Affected by Chronic Lymphocytic Leukemia 2014 LEANZA, LUIGIFREZZATO, FEDERICATRENTIN, LIVIOSEMENZATO, GIANPIETRO CARLOZORATTI, MARIOSZABO', ILDIKO' BIOPHYSICAL JOURNAL - 58th Annual Meeting of the Biophysical-Society
Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia. 2013 LEANZA, LUIGITRENTIN, LIVIOFREZZATO, FEDERICAZORATTI, MARIOSEMENZATO, GIANPIETRO CARLOSZABO', ILDIKO' + LEUKEMIA - -
Compensatory expression of NRF2-dependent antioxidant genes is required to overcome the lethal effects of Kv11.1 activation in breast cancer cells and PDOs 2021 Leanza L.Peruzzo R. + REDOX BIOLOGY - -
Contribution of the mitochondrial potassium channel Kv1.3 to the regulation of programmed cell death 2010 LEANZA, LUIGIZORATTI, MARIOSZABO', ILDIKO' + BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS - 16th European Bioenergetics Conference
Correction: Human frataxin, the Friedreich ataxia deficient protein, interacts with mitochondrial respiratory chain (Cell Death & Disease, (2023), 14, 12, (805), 10.1038/s41419-023-06320-y) 2024 Doni D.Bortolus M.Baschiera E.d'Ettorre F.Ottaviani D.Leanza L.Greggio E.Ziviani E.Bellin M.Carbonera D.Salviati L.Costantini P. + CELL DEATH & DISEASE - -
Correlation between potassium channel expression and sensitivity to drug-induced cell death in tumor cell lines 2014 LEANZA, LUIGIZORATTI, MARIOSZABO', ILDIKO' + CURRENT PHARMACEUTICAL DESIGN - -
Correlation between potassium channel expression and sensitivity to drug-induced cell death in tumor cell lines. 2013 LEANZA, LUIGIZORATTI, MARIOSZABO', ILDIKO' + CURRENT PHARMACEUTICAL DESIGN - -
Corrigendum to “Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family” [Redox Biol. 37 (2020 Sep 6) 101705–101721](S2213231720309101)(10.1016/j.redox.2020.101705) 2021 Peruzzo R.Mattarei A.Azzolini M.Romio M.Rigoni G.Carrer A.Biasutto L.Parrasia S.Urbani A.Rossa A.Semenzato G.Soriano M. E.Trentin L.Paradisi C.Zoratti M.Leanza L.Szabo I. + REDOX BIOLOGY - -
Derivati dello psoralene come agenti anti-tumorali selettivi 2017 Biasutto LuciaLeanza LuigiManago' AntonellaMattarei AndreaParadisi CristinaRomio MatteoSemenzato GianpietroSzabo IldikoTrentin LivioZoratti Mario - - -
Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo 2017 LEANZA, LUIGIROMIO, MATTEOAZZOLINI, MICHELETRENTIN, LIVIOMANAGO', ANTONELLAVENTURINI, ELISAMATTAREI, ANDREACARRARETTO, LUCAURBANI, ANDREABIASUTTO, LUCIAMARTINI, VERONICASEVERIN, FILIPPOPERUZZO, ROBERTATRIMARCO, VALENTINAVISENTIN, ANDREASEMENZATO, GIANPIETRO CARLOZORATTI, MARIOPARADISI, CRISTINASZABO', ILDIKO' + CANCER CELL - -
Early effects of the antineoplastic agent salinomycin on mitochondrial function 2015 MANAGO', ANTONELLALEANZA, LUIGICARRARETTO, LUCASASSI, NICOLAGRANCARA, SILVIAQUINTANA-CABRERA, RUBENTRIMARCO, VALENTINATONINELLO, ANTONIOSCORRANO, LUCATRENTIN, LIVIOZORATTI, MARIOSZABO', ILDIKO' + CELL DEATH & DISEASE - -
Excessive Accumulation of Ca2 + in Mitochondria of Y522S-RYR1 Knock-in Mice: A Link Between Leak From the Sarcoplasmic Reticulum and Altered Redox State 2019 Canato M.Capitanio P.Cancellara L.Leanza L.Raffaello A.Reane D. V.Marcucci L.PROTASI, FELICIANOReggiani C. + FRONTIERS IN PHYSIOLOGY - -
Exploiting pyocyanin to treat mitochondrial disease due to respiratory complex III dysfunction 2021 Peruzzo, RobertaCorrà, SamanthaCosta, RobertoBrischigliaro, MicheleVaranita, TatianaRampazzo, ChiaraLeanza, LuigiZeviani, MassimoDe Pittà, CristianoViscomi, CarloCosta, RodolfoSzabò, Ildikò + NATURE COMMUNICATIONS - -
From channels to canonical wnt signaling: A pathological perspective 2021 Muccioli S.Brillo V.Chieregato L.Leanza L.Checchetto V.Costa R. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - -
Human frataxin, the Friedreich ataxia deficient protein, interacts with mitochondrial respiratory chain 2023 Davide DoniMarco BortolusElisa BaschieraFederica D'EttorreDaniele OttavianiLuigi LeanzaElisa GreggioElena ZivianiAntonella RussoMilena BellinGeppo SartoriDonatella CarboneraLeonardo SalviatiPaola Costantini + CELL DEATH & DISEASE - -